Aurobindo Pharma Ltd (ARBP) ABRP has witnessed strong growth in different business verticals like Injectables, ARV, API and Growthmatkets. ABRP has planned to incur capex of USD$ 180mn - USD$ 200mn in Injectibles and Biosimilars to drive growth in upcoming years.